← SynDRA

GSK-256066

SynDRA canonical compound SYN0020245 — structure-anchored drug synonym record

Clinical phasePhase 2
Primary target(s)PDE4A | PDE4B | PDE4C | PDE4D
Mechanism of actionphosphodiesterase inhibitor

All known targets

Mechanisms of action (all sources)

Cross-references

Synonyms

Look up GSK-256066 in the interactive SynDRA portal →